Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Imatinib Mesylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 959Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 2ACCORD HEALTHCARE INC

    02 2APOTEX INC

    03 2JAMP PHARMA CORPORATION

    04 2MINT PHARMACEUTICALS INC

    05 2NATCO PHARMA (CANADA) INC

    06 2NOVARTIS PHARMACEUTICALS CANADA INC

    07 2Pharmascience Inc.

    08 2SANIS HEALTH INC

    09 2SIVEM PHARMACEUTICALS ULC

    10 2TEVA CANADA LIMITED

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    APOTEX INC

    Canada
    2024 ACI Convention
    Not Confirmed
    arrow

    APOTEX INC

    Canada
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    IMATINIB (IMATINIB MESYLATE)

    Brand Name : APO-IMATINIB

    Dosage Form : TABLET

    Dosage Strength : 100MG

    Packaging : 30/100

    Approval Date :

    Application Number : 2355337

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    APOTEX INC

    Canada
    2024 ACI Convention
    Not Confirmed
    arrow

    APOTEX INC

    Canada
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    IMATINIB (IMATINIB MESYLATE)

    Brand Name : APO-IMATINIB

    Dosage Form : TABLET

    Dosage Strength : 400MG

    Packaging : 30/500

    Approval Date :

    Application Number : 2355345

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    MINT PHARMACEUTICALS INC

    Canada
    2024 ACI Convention
    Not Confirmed
    arrow

    MINT PHARMACEUTICALS INC

    Canada
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    IMATINIB (IMATINIB MESYLATE)

    Brand Name : MINT-IMATINIB

    Dosage Form : TABLET

    Dosage Strength : 100MG

    Packaging :

    Approval Date :

    Application Number : 2492334

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    MINT PHARMACEUTICALS INC

    Canada
    2024 ACI Convention
    Not Confirmed
    arrow

    MINT PHARMACEUTICALS INC

    Canada
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    IMATINIB (IMATINIB MESYLATE)

    Brand Name : MINT-IMATINIB

    Dosage Form : TABLET

    Dosage Strength : 400MG

    Packaging :

    Approval Date :

    Application Number : 2492342

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    NOVARTIS PHARMACEUTICALS CANADA INC

    Switzerland
    2024 ACI Convention
    Not Confirmed
    arrow

    NOVARTIS PHARMACEUTICALS CANADA INC

    Switzerland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    IMATINIB (IMATINIB MESYLATE)

    Brand Name : GLEEVEC

    Dosage Form : TABLET

    Dosage Strength : 100MG

    Packaging : 120

    Approval Date :

    Application Number : 2253275

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    NOVARTIS PHARMACEUTICALS CANADA INC

    Switzerland
    2024 ACI Convention
    Not Confirmed
    arrow

    NOVARTIS PHARMACEUTICALS CANADA INC

    Switzerland
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Switzerland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    IMATINIB (IMATINIB MESYLATE)

    Brand Name : GLEEVEC

    Dosage Form : TABLET

    Dosage Strength : 400MG

    Packaging : 30

    Approval Date :

    Application Number : 2253283

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Pharmascience Inc.

    Canada
    2024 ACI Convention
    Not Confirmed
    arrow

    Pharmascience Inc.

    Canada
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    IMATINIB MESYLATE

    Brand Name : PMS-IMATINIB

    Dosage Form : TABLET

    Dosage Strength : 100MG

    Packaging : 120

    Approval Date :

    Application Number :

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Pharmascience Inc.

    Canada
    2024 ACI Convention
    Not Confirmed
    arrow

    Pharmascience Inc.

    Canada
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Canada
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    IMATINIB MESYLATE

    Brand Name : PMS-IMATINIB

    Dosage Form : TABLET

    Dosage Strength : 400MG

    Packaging : 30

    Approval Date :

    Application Number :

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    TEVA CANADA LIMITED

    Israel
    2024 ACI Convention
    Not Confirmed
    arrow

    TEVA CANADA LIMITED

    Israel
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    IMATINIB (IMATINIB MESYLATE)

    Brand Name : TEVA-IMATINIB

    Dosage Form : TABLET

    Dosage Strength : 100MG

    Packaging : 100/120/500

    Approval Date :

    Application Number : 2399806

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    TEVA CANADA LIMITED

    Israel
    2024 ACI Convention
    Not Confirmed
    arrow

    TEVA CANADA LIMITED

    Israel
    arrow
    2024 ACI Convention
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Regulatory Info : Prescription

    Registration Country : Canada

    IMATINIB (IMATINIB MESYLATE)

    Brand Name : TEVA-IMATINIB

    Dosage Form : TABLET

    Dosage Strength : 400MG

    Packaging : 30/100/500

    Approval Date :

    Application Number : 2399814

    Regulatory Info : Prescription

    Registration Country : Canada

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF